Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) EBIT Margin (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBIT Margin data on record, last reported at 15.56% in Q3 2025.

  • For Q3 2025, EBIT Margin rose 82.0% year-over-year to 15.56%; the TTM value through Sep 2025 reached 1.12%, down 1016.0%, while the annual FY2024 figure was 1.82%, 889.0% down from the prior year.
  • EBIT Margin reached 15.56% in Q3 2025 per CLB's latest filing, up from 11.75% in the prior quarter.
  • Across five years, EBIT Margin topped out at 15.56% in Q3 2025 and bottomed at 26.95% in Q4 2024.
  • Average EBIT Margin over 4 years is 8.02%, with a median of 11.71% recorded in 2023.
  • The widest YoY moves for EBIT Margin: up 303bps in 2024, down -3832bps in 2024.
  • A 4-year view of EBIT Margin shows it stood at 12.24% in 2022, then fell by -7bps to 11.37% in 2023, then tumbled by -337bps to 26.95% in 2024, then soared by 158bps to 15.56% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 15.56% in Q3 2025, 11.75% in Q2 2025, and 3.57% in Q1 2025.